Latest Breaking News On - Chief neuropsychiatric consultant - Page 1 : comparemela.com

/PRNewswire/ MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical company focused on the development and.

United statesErez aminovAdam kaplinCannabinoid derived drug development summitUs drug enforcement administrationJohns hopkins ms centerPharmaceuticals incAmira pharmaceuticalsCannabinoid derived drug developmentChief scientific officerChief neuropsychiatric consultantJohns hopkinsJohns hopkins ketamine clinicChief executive officerEnforcement administrationControlled substances act